No trading action warranted. This is a routine, non-material update required under French financial regulations. Monitor upcoming clinical trial updates or earnings for substantive developments.
Price Chart
Executive Summary
Nanobiotix filed a routine 6-K disclosing its voting rights and share capital as of March 31, 2026, showing 48,517,630 shares outstanding and 50,143,014 exercisable voting rights. This is a standard regulatory update with no material financial or operational implications.
Key Facts
- As of March 31, 2026, Nanobiotix had 48,517,630 shares outstanding.
- Total theoretical voting rights: 50,165,132.
- Total exercisable voting rights: 50,143,014.
- Filing is pursuant to French regulatory requirements for foreign private issuers.
Financial Impact
No financial impact — this is a disclosure of share and voting rights data only.
Risk Factors
- None associated with this filing.
- General biotech development risk remains given the company's late-stage clinical status.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001171843-26-002299 |
| Document: f6k_040726.htm | 0001171843-26-002299 |
| Document: 0001171843-26-002299-index-headers.html | 0001171843-26-002299 |
| Document: 0001171843-26-002299-index.html | 0001171843-26-002299 |
| Document: 0001171843-26-002299.txt | 0001171843-26-002299 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 26, 2026 today | 6-K | — | awaiting T+20 | — | — |
Oct 20, 2026 6d ago | 6-K | $25.83 | awaiting T+20 | — | $31.53 (+22.07%) |
Oct 1, 2026 25d ago | 6-K | $25.75 | awaiting T+20 | — | $31.53 (+22.45%) |
Oct 1, 2026 25d ago | Press Release | $25.75 | awaiting T+20 | — | $31.53 (+22.45%) |
Sep 24, 2026 4w ago | 6-K | $33.31 $29.36 | ▲ +11.86% | ▲ +10.38% | $31.53 (+5.34%) |
Sep 24, 2026 4w ago | 6-K | $33.31 $29.36 | ▼ −11.86% | ▼ −10.38% | $31.53 (−5.34%) |
Sep 24, 2026 4w ago | Press Release | $33.31 $29.36 | ▼ −11.86% | ▼ −10.38% | $31.53 (−5.34%) |
Sep 22, 2026 4w ago | Press Release | $35.24 $25.83 | ▼ −26.70% | ▼ −27.39% | $31.53 (−10.53%) |
Sep 14, 2026 6w ago | 6-K | $35.73 $23.40 | ▼ −34.51% | ▼ −36.77% | $31.53 (−11.75%) |
Jul 31, 2026 12w ago | 6-K | $38.89 $40.64 | ▲ +4.50% | ▲ +3.26% | $31.53 (−18.93%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers